Johnson & Johnson has announced new data from an analysis modelling long-term progression free survival (PFS) in transplant ...

Speculation about the US Administration’s views on the Benefits Scheme (PBS) has reconfirmed the sanctity of the PBS as the ...

Indian drugmaker Sun (BSE: 524715) shares were buzzing in trade on the last trading day of the week to April 11, rising as ...

US biotech Imbria Pharmaceuticals has raised $57.5 million in a series B financing round to fund a new mid-stage trial of its ...

US biopharma company Palatin Technologies (NYSE American: PTN) is at risk of being removed from the NYSE American exchange ...

The US Centers for Medicare & Medicaid Services (CMS) has announced action intended to preserve the core mission of the ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s (LSE: AZN) Truqap ...

Russell Abberley, vice president and general manager of US biotech giant Amgen’s (Nasdaq: AMGN) UK and Ireland unit, has been ...

Swiss pharma giant Novartis (NOVN: VX) has announced a planned $23 billion investment over five years in US-based ...

Australian biotech Opthea (Nasdaq: OPT) is cutting around two-thirds of its workforce, as the company moves to curb spending ...

Late Thursday, the US Food and Drug Administration revealed it is taking a ground-breaking step to advance public health by ...

US biotech Atossa Therapeutics (Nasdaq: ATOS) has entered into a research collaboration with China-backed Nona Biosciences, ...